お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974154

薬物スクリーニングの世界市場 (~2025年):製品 (消耗品・尿検査デバイス・分析機器・呼気アナライザー・クロマトグラフィー)・サービス・検体タイプ (尿・呼気)・エンドユーザー (職場・ラボ・刑事司法・病院)・地域別

Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 185 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
薬物スクリーニングの世界市場 (~2025年):製品 (消耗品・尿検査デバイス・分析機器・呼気アナライザー・クロマトグラフィー)・サービス・検体タイプ (尿・呼気)・エンドユーザー (職場・ラボ・刑事司法・病院)・地域別
出版日: 2020年12月02日
発行: MarketsandMarkets
ページ情報: 英文 185 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の薬物スクリーニングの市場規模は予測期間中17.3%のCAGRで推移し、2020年の45億米ドルから、2025年には100億米ドルの規模に成長すると予測されています。薬物とアルコールの消費量の増加、検査義務に関する厳格な法律の施行、政府による資金投入、規制当局の承認、製品とサービスの発売などの要因が同市場の成長を推進しています。一方、イスラム諸国での飲酒の禁止や特定の地域での職場での薬物検査の禁止が市場のさらなる成長の妨げとなっています。

検体別で見ると、尿検体の部門が予測期間中の市場をリードすると予測されています。複数の薬物の検出における高精度性、費用対効果、即時の結果などのメリットが同部門の成長を牽引しています。また、地域別では、北米地域が期間中最大のシェアを示す見通しであり、成長率ではアジアが最大のCAGRを示す見通しです。

当レポートでは、世界の薬物スクリーニングの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、製品&サービス・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • バリューチェーン分析
  • エコシステム
  • COVID-19の影響

第6章 市場分析・予測:製品・サービス別

  • サービス
  • 製品
    • 分析機器
    • 迅速検査デバイス
    • 消耗品

第7章 市場分析・予測:検体タイプ別

  • 尿検体
  • 呼気検体
  • 経口液検体
  • 毛髪検体
  • その他

第8章 市場分析・予測:エンドユーザー別

  • 職場
  • 薬物検査ラボ
  • 刑事司法・法執行機関
  • 病院
  • 薬物治療センター
  • 個人
  • 疼痛管理センター
  • 学校・大学

第9章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 競合状況・動向

第11章 企業評価マトリックス・企業プロファイル

  • 企業評価マトリックス:定義・調査手法
  • 企業評価マトリックス
  • 競合リーダーシップマッピング
  • 企業プロファイル
    • LABCORP
    • QUEST DIAGNOSTICS
    • ALERE
    • ORASURE
    • ALFA SCIENTIFIC DESIGNS
    • THERMO FISHER SCIENTIFIC
    • DRAGERWERK
    • LIFELOC
    • MPD INC.
    • OMEGA LABORATORIES
    • PREMIER BIOTECH
    • PSYCHEMEDICS
    • ROCHE
    • SHIMADZU
    • SIEMENS HEALTHINEERS
    • AMERICAN BIO MEDICA CORPORATION
    • SCITECK, INC.
    • ACM GLOBAL LABORATORIES
    • CAREHEALTH AMERICA
    • CLINICAL REFERENCE LABORATORY

第12章 付録

目次
Product Code: MD 3239

The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.

"Drug screening services are expected to grow at the highest CAGR during the forecast period"

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

By sample type, urine samples are expected to dominate the market during the forecast period"

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

"North America will dominate the market during the forecast period."

Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug screening market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
  • By Designation - C-level: 25%, D-level: 44%, and Others: 33%
  • By Region - North America: 40%, Europe: 29%, Asia Pacific: 19%, and Rest of the World: 12%

List of Companies Profiled in the Report

  • LabCorp (US)
  • Alere (US)
  • Thermo Fisher (US)
  • Dragerwerk (Germany)
  • Quest Diagnostics (US)
  • Alfa Scientific Designs (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • OraSure (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Roche (Switzerland)
  • Shimadzu (Japan)
  • Seimens Healthineers (US)
  • American Bio Medica Corporation (US)
  • Sciteck, Inc. (US)
  • ACM Global Laboratories (US)
  • CareHealth America (US)
  • Clinical Reference Laboratory (US)

Research Coverage:

This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on drug screening offered by the top 20 players in the drug screeningmarket. The report analyses the drug screeningmarket by product and service, sample type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening fmarket.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
  • 2.2 SECONDARY DATA
    • 2.2.1 KEY DATA FROM SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • 2.3.1 PRIMARY SOURCES
    • 2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • 2.4 MARKET ESTIMATION
    • 2.4.1 BOTTOM-UP APPROACH
    • 2.4.2 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
    • FIGURE 4 DRUG SCREENING MARKET: TOP-DOWN APPROACH
    • 2.4.3 GROWTH FORECAST
  • 2.5 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 6 DRUG SCREENING SERVICES MARKET TO RECORD HIGHEST CAGR DURING 2020-2025
    • FIGURE 7 ANALYTICAL INSTRUMENTS SEGMENT TO LEAD THE DRUG SCREENING PRODUCTS MARKET, 2020-2025 (USD BILLION)
    • FIGURE 8 WORKPLACES TO SHOW THE HIGHEST GROWTH IN THE END-USER MARKET, 2020-2025 (USD BILLION)
    • FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE DRUG SCREENING MARKET

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN THE DRUG SCREENING MARKET
    • FIGURE 10 GROWING CONSUMPTION OF DRUGS AND ALCOHOL TO DRIVE MARKET GROWTH
  • 4.2 DRUG SCREENING MARKET, BY PRODUCT & SERVICE
    • FIGURE 11 SERVICES SEGMENT TO REGISTER HIGHEST CAGR DURING 2020-2025 (USD BILLION)
  • 4.3 DRUG SCREENING MARKET, BY SAMPLE TYPE
    • FIGURE 12 ORAL FLUID SAMPLES SEGMENT TO WITNESS HIGHEST CAGR, 2020-2025 (USD BILLION)
  • 4.4 DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT
    • FIGURE 13 INDIA TO WITNESS HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.3 MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growing drug and alcohol consumption
      • 5.3.1.2 Enforcement of stringent laws mandating drug and alcohol testing
      • 5.3.1.3 Regulatory approvals and product & service launches
    • TABLE 1 KEY PRODUCT & SERVICE LAUNCHES (2014-2017)
    • TABLE 2 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Ban on alcohol consumption in several Islamic countries
      • 5.3.2.2 Prohibition on workplace drug testing in some countries
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Oral fluid testing
      • 5.3.3.2 Fingerprint-based drug screening
      • 5.3.3.3 Emerging economies
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Accuracy and specificity concerns related to breathalyzers
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 15 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 ECOSYSTEM ANALYSIS OF THE DRUG SCREENING PRODUCTS MARKET
    • FIGURE 16 ECOSYSTEM ANALYSIS
  • 5.6 COVID-19 IMPACT ON THE DRUG SCREENING MARKET

6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 3 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 6.2 DRUG SCREENING SERVICES
    • 6.2.1 GROWING DRUG CONSUMPTION AND STRINGENT LAWS HAVE ENSURED DEMAND SPIKE FOR SERVICES
    • TABLE 4 DRUG SCREENING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 DRUG SCREENING PRODUCTS
    • TABLE 5 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 6.3.1 ANALYTICAL INSTRUMENTS
    • TABLE 6 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 7 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.1.1 Breathalyzers
        • 6.3.1.1.1 Law enforcement agencies widely use breathalyzers
    • TABLE 8 BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 9 BREATHALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.1.1.2 Fuel-cell breathalyzers
    • TABLE 10 FUEL-CELL BREATHALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.1.1.3 Semiconductor breathalyzers
    • TABLE 11 SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.1.1.4 Other breathalyzers
    • TABLE 12 OTHER BREATHALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.1.2 Immunoassay analyzers
        • 6.3.1.2.1 North America is the largest market for immunoassay analyzers
    • TABLE 13 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.1.3 Chromatography instruments
        • 6.3.1.3.1 Chromatography shows higher accuracy than immunoassays
    • TABLE 14 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.2 RAPID TESTING DEVICES
    • TABLE 15 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 16 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.2.1 Urine testing devices
        • 6.3.2.1.1 Urine testing provides results within minutes and is used in a wide range of applications
    • TABLE 17 URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 18 URINE TESTING DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.2.1.2 Drug testing cups
    • TABLE 19 DRUG TESTING CUPS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.2.1.3 Dip cards
    • TABLE 20 DIP CARDS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • 6.3.2.1.4 Drug testing cassettes
    • TABLE 21 DRUG TESTING CASSETTES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.2.2 Oral fluid testing devices
        • 6.3.2.2.1 Short detection windows, noninvasive nature, and low chance of sample tampering have ensured interest in oral fluid testing
    • TABLE 22 ORAL FLUID TESTING DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.3 CONSUMABLES
    • TABLE 23 DRUG SCREENING CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 24 DRUG SCREENING CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.3.1 Assay kits
        • 6.3.3.1.1 Immunoassay kits provide a rapid, inexpensive method to screen samples
    • TABLE 25 ASSAY KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.3.2 Sample collection devices
        • 6.3.3.2.1 APAC market for sample collection devices to see high growth
    • TABLE 26 SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.3.3 Calibrators & controls
        • 6.3.3.3.1 Thermo Fisher Scientific is a prominent manufacturer of calibrators & controls
    • TABLE 27 CALIBRATORS & CONTROLS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 6.3.3.4 Other consumables
    • TABLE 28 OTHER CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)

7 DRUG SCREENING MARKET, BY SAMPLE TYPE

  • 7.1 INTRODUCTION
    • TABLE 29 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
  • 7.2 URINE SAMPLES
    • 7.2.1 EASE OF COLLECTION AND WELL-DEVELOPED TECHNOLOGY HAVE SUPPORTED THE USE OF URINE SAMPLES
    • TABLE 30 DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 BREATH SAMPLES
    • 7.3.1 BREATH ALCOHOL TESTS SEE WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS
    • TABLE 31 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 ORAL FLUID SAMPLES
    • 7.4.1 NONINVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION HAVE SUPPORTED RELIANCE ON ORAL SAMPLES
    • TABLE 32 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION, 2018-2025 (USD MILLION)
  • 7.5 HAIR SAMPLES
    • 7.5.1 HAIR SAMPLES CAN PROVIDE INSIGHTS INTO LONG-TERM DRUG USE
    • TABLE 33 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION, 2018-2025 (USD MILLION)
  • 7.6 OTHER SAMPLES
    • TABLE 34 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2018-2025 (USD MILLION)

8 DRUG SCREENING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 35 DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 WORKPLACES
    • 8.2.1 WORKPLACES TO SHOW THE HIGHEST GROWTH OF ALL END-USER SEGMENTS
    • TABLE 36 DRUG SCREENING MARKET FOR WORKPLACES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 DRUG TESTING LABORATORIES
    • 8.3.1 RISING NUMBER OF DRUG ABUSE CASES AND DEVELOPMENT OF SPECIALIZED ASSAYS AND TESTS SUPPORT MARKET GROWTH
    • TABLE 37 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES
    • 8.4.1 URINE IS THE MOST COMMONLY USED SAMPLE IN CRIMINAL JUSTICE SYSTEMS
    • TABLE 38 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 HOSPITALS
    • 8.5.1 RISING DRUG ABUSE INCIDENCE HAS RESULTED IN AN INCREASE IN EMERGENCY DEPARTMENT VISITS
    • TABLE 39 DRUG SCREENING MARKET FOR HOSPITALS, BY REGION, 2018-2025 (USD MILLION)
  • 8.6 DRUG TREATMENT CENTERS
    • 8.6.1 AVAILABILITY OF GOVERNMENT SUPPORT IS A KEY GROWTH DRIVER
    • TABLE 40 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.7 INDIVIDUAL USERS
    • 8.7.1 PERSONAL BREATHALYZERS HAVE SEEN GROWING ADOPTION
    • TABLE 41 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.8 PAIN MANAGEMENT CENTERS
    • 8.8.1 RISING SUBSTANCE ABUSE HAS SUPPORTED DRUG TESTING ACTIVITY IN PAIN MANAGEMENT APPLICATIONS
    • TABLE 42 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.9 SCHOOLS & COLLEGES
    • 8.9.1 WHILE SOME COUNTRIES SUPPORT DRUG TESTS IN SCHOOLS & COLLEGES, OTHERS ARE OPPOSED OR HAVE BANNED TESTING
    • TABLE 43 DRUG SCREENING MARKET FOR SCHOOLS & COLLEGES, BY REGION, 2018-2025 (USD MILLION)

9 DRUG SCREENING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 44 DRUG SCREENING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 17 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 45 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 46 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 47 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 48 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 49 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 50 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 51 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 52 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 53 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 54 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US holds the largest share of the market in North America
    • TABLE 55 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 56 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 58 US: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 59 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 61 US: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 62 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 63 US: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Canada has no legislation governing drug and alcohol testing in the workplace
    • TABLE 64 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 65 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 68 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 70 CANADA: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 71 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 72 CANADA: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 73 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 74 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 75 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 77 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 78 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 79 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 80 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 EUROPE: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest market for drug screening products & services in Europe
    • TABLE 83 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 84 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 86 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 87 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 88 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 90 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 91 GERMANY: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Cannabis and cocaine are the most widely used illicit substances in France
    • TABLE 92 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 93 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 95 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 96 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 100 FRANCE: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Favorable government support is a prominent driver of market growth in the UK
    • TABLE 101 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 102 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 103 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 104 UK: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 105 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 106 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 107 UK: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 108 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 109 UK: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 ROE
    • TABLE 110 ROE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 111 ROE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 112 ROE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 113 ROE: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 ROE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 115 ROE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 ROE: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 117 ROE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 118 ROE: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 APAC
    • FIGURE 18 APAC: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 119 APAC: DRUG SCREENING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 120 APAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 121 APAC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 122 APAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 123 APAC: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 124 APAC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 125 APAC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 126 APAC: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 127 APAC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 128 APAC: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China holds the largest share of the APAC market
    • TABLE 129 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 130 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 131 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 132 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 133 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 134 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 CHINA: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 CHINA: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Stringent laws and growing awareness are key market drivers in Japan
    • TABLE 138 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 139 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 140 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 141 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 142 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 143 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 144 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 145 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 JAPAN: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 India is among the fastest-growing segments of the drug screening market
    • TABLE 147 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 148 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 149 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 150 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 151 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 152 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 153 INDIA: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 154 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 155 INDIA: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 ROAPAC
    • TABLE 156 ROAPAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 157 ROAPAC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 158 ROAPAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 159 ROAPAC: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 160 ROAPAC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 161 ROAPAC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 162 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 163 ROAPAC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 164 ROAPAC: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 ROW
    • TABLE 165 ROW: DRUG SCREENING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 166 ROW: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 167 ROW: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 168 ROW: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 169 ROW: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 170 ROW: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 171 ROW: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 172 ROW: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 173 ROW: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 ROW: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.5.1 LATAM
      • 9.5.1.1 Increasing incidence of drug overdose and favorable government support are key growth drivers in LATAM
    • TABLE 175 LATAM: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 176 LATAM: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 177 LATAM: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 178 LATAM: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 179 LATAM: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 180 LATAM: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 181 LATAM: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 182 LATAM: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 183 LATAM: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.5.2 MIDDLE EAST & AFRICA
      • 9.5.2.1 Rising drug abuse and growing emphasis on testing support market growth in the MEA
    • TABLE 184 MEA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 185 MEA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 186 MEA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 187 MEA: BREATHALYZERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 188 MEA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 189 MEA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 190 MEA: CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 191 MEA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
    • TABLE 192 MEA: DRUG SCREENING MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 19 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
    • FIGURE 20 MARKET EVOLUTION FRAMEWORK
  • 10.2 COMPETITIVE SITUATIONS AND TRENDS
    • 10.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2020)
    • 10.2.2 PRODUCT LAUNCHES (2017-2020)
    • 10.2.3 APPROVALS (2017-2020)
    • 10.2.4 EXPANSIONS (2017-2020)
    • 10.2.5 ACQUISITIONS (2017-2020)

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 11.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
    • 11.1.1 MARKET PLAYER RANKING, 2019
    • FIGURE 21 DRUG SCREENING SERVICES MARKET RANKING, BY KEY PLAYER, 2019
    • FIGURE 22 RAPID TESTING DEVICES MARKET RANKING, BY KEY PLAYER, 2019
  • 11.2 COMPANY EVALUATION MATRIX
    • 11.2.1 STARS
    • 11.2.2 EMERGING LEADERS
    • 11.2.3 PERVASIVE PLAYERS
    • 11.2.4 PARTICIPANTS
    • FIGURE 23 MNM VENDOR DIVE COMPARISON MATRIX: DRUG SCREENING MARKET
  • 11.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
    • 11.3.1 PROGRESSIVE COMPANIES
    • 11.3.2 STARTING BLOCKS
    • 11.3.3 RESPONSIVE COMPANIES
    • 11.3.4 DYNAMIC COMPANIES
    • FIGURE 24 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: DRUG SCREENING MARKET
  • 11.4 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.4.1 LABCORP
    • FIGURE 25 LABCORP: COMPANY SNAPSHOT (2019)
    • 11.4.2 QUEST DIAGNOSTICS
    • FIGURE 26 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2019)
    • 11.4.3 ALERE
    • FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
    • 11.4.4 ORASURE
    • FIGURE 28 ORASURE: COMPANY SNAPSHOTS (2019)
    • 11.4.5 ALFA SCIENTIFIC DESIGNS
    • 11.4.6 THERMO FISHER SCIENTIFIC
    • FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 11.4.7 DRAGERWERK
    • FIGURE 30 DRAGERWERK: COMPANY SNAPSHOT (2019)
    • 11.4.8 LIFELOC
    • FIGURE 31 LIFELOC: COMPANY SNAPSHOT (2019)
    • 11.4.9 MPD INC.
    • 11.4.10 OMEGA LABORATORIES
    • 11.4.11 PREMIER BIOTECH
    • 11.4.12 PSYCHEMEDICS
    • FIGURE 32 PSYCHEMEDICS: COMPANY SNAPSHOT (2019)
    • 11.4.13 ROCHE
    • FIGURE 33 ROCHE: COMPANY SNAPSHOT (2019)
    • 11.4.14 SHIMADZU
    • FIGURE 34 SHIMADZU: COMPANY SNAPSHOT (2019)
    • 11.4.15 SIEMENS HEALTHINEERS
    • FIGURE 35 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
    • 11.4.16 AMERICAN BIO MEDICA CORPORATION
    • 11.4.17 SCITECK, INC.
    • 11.4.18 ACM GLOBAL LABORATORIES
    • 11.4.19 CAREHEALTH AMERICA
    • 11.4.20 CLINICAL REFERENCE LABORATORY

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.